[1] Zhang Z et al. Melatonin: A potential nighttime guardian against Alzheimer’s. Mol Psychiatry 2024; https://doi.org/10.1038/s41380-024-02691-6
[2] Tseng PT et al. The dose and duration-dependent association between melatonin treatment and overall cognition in Alzheimer’s dementia: a network meta- analysis of randomized placebo-controlled trials. Curr Neuropharmacol; 2022; 20:1816–33; https://doi.org/10.2174/1570159X20666220420122322
[3] Sumsuzzman DM et al. Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia: A systematic review and meta-analysis of randomized controlled trials. Neurosci Biobehav Rev; 2021; 127:459–73; https://doi.org/10.1016/j.neubiorev.2021.04.034
[4] Obayashi K et al. Physiological levels of melatonin relate to cognitive function and depressive symptoms: The HEIJO-KYO Cohort. J Clin Endocrinol Metab; 2015; 100:3090–6. 221; https://doi.org/10.1210/jc.2015-1859
[5] Peck JS et al. Cognitive effects of exogenous melatonin administration in elderly persons: a pilot study. Am J Geriatr Psychiatry. 2004;12:432–6; https://doi.org/10.1176/appi.ajgp.12.4.432
[6] Marzieh SH et al. The effect of melatonin on sleep quality and cognitive function of individuals undergoing hemodialysis. Sleep Med 2023; 111:105–10; https://doi.org/10.1016/j.sleep.2023.09.011
[7] Van der Mussele S et al. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer’s dementia. Aging Ment Health 2015; 19:247–57; https://doi.org/10.1080/13607863.2014.924900
[8] Ren JJ et al. Association of night shifts and lifestyle risks with incident dementia. J Gerontol A Biol Sci Med Sci 2023; 78:1725–32; https://doi.org/10.1093/gerona/glad116
